HTB

Moderna registers HIV vaccine study

17 September 2021. Related: HIV prevention and transmission, Vaccines and microbicides.

Simon Collins, HIV i-Base

Although Moderna have not issued a press statement, several articles have reported on a new phase 1 study using mRNA vaccine approves for an HIV vaccine. [1]

The study is not yet recruiting but results are expected in 2023. [2]

References

  1. BIO news 1109. mRNA HIV vaccine trial to start. (23 August 2021).
    https://www.bionews.org.uk/page_158574
  2. ClinicalTrials.gov. A Phase 1 Study to evaluate the safety and immunogenicity of eOD-GT8 60mer mRNA vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core).
    https://clinicaltrials.gov/ct2/show/NCT05001373

Links to other websites are current at date of posting but not maintained.